Sepsis
- 26 January 2011
- journal article
- Published by Springer Science and Business Media LLC in Intensivmedizin und Notfallmedizin
- Vol. 48 (1), 57-73
- https://doi.org/10.1007/s00390-010-0249-3
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of DeathNew England Journal of Medicine, 2005
- Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsisThe American Journal of Surgery, 2004
- Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic ShockJAMA, 2002
- Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort studyIntensive Care Medicine, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Predicting Bacteremia in Patients with Sepsis SyndromeThe Journal of Infectious Diseases, 1997
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Predicting Bacteremia in Hospitalized PatientsAnnals of Internal Medicine, 1990